.jpg?format=webp&width=780)
Plasma cell-free DNA analysis has emerged as a powerful liquid biopsy assay to assess circulating tumor DNA in response to cancer treatments. A new study shows that cell-free DNA can also inform expansion kinetics and tumor-infiltration patterns in patients receiving chimeric antigen receptor T cells. Together with circulating tumor DNA, it provides vivid prognostic insights into intratumoral dynamics.
Like
Save
Share